Skip Nav Destination
Over the next year, immunity will rise to nearly 100% and be further boosted by vaccination or re-infection. As immunity becomes increasingly robust, it will get to the point where people may still catch SARS-CoV-2, but it will just be another cold. That is likely at least a year away.
Cheryl K. Gooden, MD, FASA, FAAP; Elizabeth T. Drum, MD, FAAP, FCPP, FASA
This year’s Nicholas M. Greene, MD, Outstanding Humanitarian awardee is Edward C. Clune, MD. Having come from a family of teachers, his father in math and science and mother in special education, it is no surprise that Dr. Clune found himself in the role of an educator. He has taken a decidedly different route to get there, though.
The ASA Monitor sat down with Dr. Warren M. Zapol for his insights on the specialty. As an influential researcher and scientist, Dr. Zapol’s successful trials involving the use of inhaled nitric oxide (NO) therapy in newborns are responsible for the adoption of NO therapy for hypoxemic newborns in neonatal intensive units throughout the country.
ASA® ADVANCE 2022: The Anesthesiology Business Event Is Not Your Pre-Pandemic Practice Management Meeting
ASA ADVANCE 2022: The Anesthesiology Business Event doesn’t just have a new name. The renaming signals a fully redesigned meeting, reshaped to better prepare anesthesiologists and their management teams for the real-world scenarios they could face in the coming months and years.
COVID-19 Articles & Resources
Where Did SARS-CoV-2 Come From?
Recovering From the COVID-19 Financial Crisis